Correlation Between Corvus Pharmaceuticals and Absci Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Absci Corp, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Absci Corp.

Diversification Opportunities for Corvus Pharmaceuticals and Absci Corp

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Corvus and Absci is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Absci Corp go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Absci Corp

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.72 times more return on investment than Absci Corp. However, Corvus Pharmaceuticals is 1.38 times less risky than Absci Corp. It trades about 0.05 of its potential returns per unit of risk. Absci Corp is currently generating about -0.15 per unit of risk. If you would invest  884.00  in Corvus Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  25.00  from holding Corvus Pharmaceuticals or generate 2.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Absci Corp

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Absci Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Absci Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Corvus Pharmaceuticals and Absci Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Absci Corp

The main advantage of trading using opposite Corvus Pharmaceuticals and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.
The idea behind Corvus Pharmaceuticals and Absci Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals